Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' CLODI M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 47 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Riedl, M; Clodi, M; Kotzmann, H; Hainfellner, JA; Schima, W; Reitner, A; Czech, T; Luger, A
      Apoplexy of a pituitary macroadenoma with reversible third, fourth and sixth cranial nerve palsies following administration of hypothalamic releasinghormones: MR features

      EUROPEAN JOURNAL OF RADIOLOGY
    2. Roden, M; Ludwig, C; Nowotny, P; Schneider, B; Clodi, M; Vierhapper, H; Roden, A; Waldhausl, W
      Relative hypoleptinemia in patients with type 1 and type 2 diabetes mellitus

      INTERNATIONAL JOURNAL OF OBESITY
    3. Kostner, K; Clodi, M; Bodlaj, G; Hoffmann, U; Hermann, K; Maurer, G; Pacher, R; Horl, WH
      Urinary apo(a) excretion is not altered by changes in glomerular filtration rate and renal plasma flow in healthy males

      WIENER KLINISCHE WOCHENSCHRIFT
    4. Blank, D; Riedl, M; Reitner, A; Schnack, C; Schernthaner, G; Clodi, M; Frisch, H; Luger, A
      Growth hormone replacement therapy is not associated with retinal changes

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    5. Riedl, M; Ludvik, B; Pacini, G; Clodi, M; Kotzmann, H; Wagner, O; Kautzky-Willer, A; Prager, R; Luger, A
      The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    6. Vollenweider, P; Clodi, M; Martin, SS; Imamura, T; Kavanaugh, WM; Olefsky, JM
      An SH2 domain-containing 5 ' inositolphosphatase inhibits insulin-induced GLUT4 translocation and growth factor-induced actin filament rearrangement

      MOLECULAR AND CELLULAR BIOLOGY
    7. Imamura, T; Vollenweider, P; Egawa, K; Clodi, M; Ishibashi, K; Nakashima, N; Ugi, S; Adams, JW; Brown, JH; Olefsky, JM
      G alpha-q/11 protein plays a key role in insulin-induced glucose transportin 3T3-L1 adipocytes

      MOLECULAR AND CELLULAR BIOLOGY
    8. Clodi, M; Oberbauer, R; Bodlaj, G; Hofmann, J; Maurer, G; Kostner, K
      Urinary excretion of apolipoprotein(a) fragments in type 1 diabetes mellitus patients

      METABOLISM-CLINICAL AND EXPERIMENTAL
    9. CLODI M; RIEDL M; SCHMALDIENST S; VYCHYTIL A; KOTZMANN H; KAIDER A; BIEGLMAYER C; MAYER G; WALDHAUSL W; LUGER A
      ADRENAL-FUNCTION IN PATIENTS WITH CHRONIC-RENAL-FAILURE

      American journal of kidney diseases
    10. CLODI M; THOMASETH K; PACINI G; HERMANN K; KAUTZKYWILLER A; WALDHAUSL W; PRAGER R; LUDVIK B
      DISTRIBUTION AND KINETICS OF AMYLIN IN HUMANS

      American journal of physiology: endocrinology and metabolism
    11. KOTZMANN H; RIEDL M; BERNECKER P; CLODI M; KAINBERGER F; KAIDER A; WOLOSZCZUK W; LUGER A
      EFFECT OF LONG-TERM GROWTH-HORMONE SUBSTITUTION THERAPY ON BONE-MINERAL DENSITY AND PARAMETERS OF BONE METABOLISM IN ADULT PATIENTS WITH GROWTH-HORMONE DEFICIENCY

      Calcified tissue international
    12. KOSTNER KM; CLODI M; BODLAJ G; WATSCHINGER B; HORL W; DERFLER K; HUBER K
      DECREASED URINARY APOLIPOPROTEIN (A) EXCRETION IN PATIENTS WITH IMPAIRED RENAL-FUNCTION

      European journal of clinical investigation
    13. KOTZMANN H; KOLLER M; ABELA C; CLODI M; RIEDL M; GRANINGER W; NIEDERLE B; LUGER A
      EFFECTS OF PARATHYROID-HORMONE AND SERUM-CALCIUM ON THE PHENOTYPE ANDFUNCTION OF MONONUCLEAR-CELLS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM

      European journal of clinical investigation
    14. CLODI M; VOLLENWEIDER P; KLARLUND J; NAKASHIMA N; MARTIN S; CZECH MP; OLEFSKY JM
      EFFECTS OF GENERAL RECEPTOR FOR PHOSPHOINOSITIDES-1 ON INSULIN AND INSULIN-LIKE-GROWTH-FACTOR I-INDUCED CYTOSKELETAL REARRANGEMENT, GLUCOSETRANSPORTER-4 TRANSLOCATION, AND DEOXYRIBONUCLEIC-ACID SYNTHESIS

      Endocrinology
    15. LUDVIK B; THOMASETH K; CLODI M; NOLAN J; PRAGER R; PACINI G; OLEFSKY J
      EVIDENCE FOR MODULATION OF POSTPRANDIAL GLUCAGON-SECRETION BY ENDOGENOUS AMYLIN IN MAN

      Diabetologia
    16. CLODI M; VOLLENWEIDER P; KLARLUND J; NAKASHIMA N; OLEFSKY J
      EFFECTS OF GRP1 (GENERAL RECEPTOR FOR PHOSPHOINOSITIDES-1) ON INSULINAND IGF-I INDUCED GLUT-4 TRANSLOCATION, MEMBRANE RUFFLING AND DNA-SYNTHESIS

      Diabetes
    17. LUDVIK B; THOMASETH K; CLODI M; PRAGER R; PACINI G
      RELATIONSHIP BETWEEN ENDOGENOUS AMYLIN AND GLUCAGON-SECRETION IN HUMAN-SUBJECTS

      Diabetes
    18. VOLLENWEIDER P; CLODI M; IMAMURA T; MARTIN S; OLEFSKY JM
      OVEREXPRESION OF AN SH2 CONTAINING 5'INOSITOLPHOSPHATASE (SHIP) INHIBITS INSULIN-INDUCED GLUT4 TRANSLOCATION AND GROWTH-FACTOR INDUCED ACTIN FILAMENT REARRANGEMENT

      Diabetes
    19. CLODI M; KOTZMANN H; RIEDL M; SCHMIDT A; BARNAS U; MUHLBACHER F; MUSTAFA G; HORL WH; WALDHAUSL W; MAYER G; LUGER A
      THE LONG-ACTING DOPAMINE AGONIST BROMOCRIPTINE MESYLATE AS ADDITIVE IMMUNOSUPPRESSIVE DRUG AFTER KIDNEY-TRANSPLANTATION

      Nephrology, dialysis, transplantation
    20. THOMASETH K; PACINI G; CLODI M; KAUTZKYWILLER A; NOLAN JJ; PRAGER R; OLEFSKY JM; LUDVIK B
      AMYLIN RELEASE DURING ORAL GLUCOSE-TOLERANCE TEST

      Diabetic medicine
    21. KOSTNER K; CLODI M; OBERBAUER R; WALDHAUSL W; MAURER G; KOSTNER G
      URINARY-EXCRETION OF APO(A) FRAGMENTS IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS PATIENTS

      Atherosclerosis
    22. KOTZMANN H; ABELA C; HEINDL J; CLODI M; RIEDL M; BARNAS U; HEINZL H; NIEDERLE B; GEISSLER K; WALDHAUSL W; LUGER A
      EFFECT OF SUCCESSFUL PARATHYROIDECTOMY ON HEMATOPOIETIC PROGENITOR CELLS AND PARAMETERS OF RED-BLOOD-CELLS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM

      Hormone and Metabolic Research
    23. KOLLER M; KOTZMANN H; CLODI M; RIEDL M; LUGER A
      EFFECT OF ELEVATED SERUM PROLACTIN CONCENTRATIONS ON THE IMMUNOPHENOTYPE OF HUMAN-LYMPHOCYTES, MITOGEN-INDUCED PROLIFERATION AND PHAGOCYTIC-ACTIVITY OF POLYMORPHONUCLEAR CELLS

      European journal of clinical investigation
    24. CLODI M; OBERBAUER R; WALDHAUSL W; MAURER G; KOSTNER GM
      URINARY-EXCRETION OF APO(A) FRAGMENTS IN NIDDM PATIENTS

      Diabetologia
    25. CLODI M; HERMANN K; PACINI G; THOMASETH K; KAUTZKYWILLER A; PRAGER R; LUDVIK B
      ISLET AMYLOID POLYPEPTIDE DISTRIBUTION AND KINETICS IN HUMANS AND ITSRELATIONSHIP TO KIDNEY-FUNCTION

      Journal of investigative medicine
    26. HOFFMANN U; KUREK C; KOSTNER K; SCHOLTEN C; CLODI M; LANG I; STEFENELLI T
      ATYPICAL ELEVATION OF CREATINE-PHOSPHOKINASE AND ISOENZYME (CK-MB) LEVELS IN A PATIENT WITH MITRAL-VALVE DISEASE

      European heart journal
    27. KAUTZKYWILLER A; THOMASETH K; CLODI M; LUDVIK B; WALDHAUSL W; PRAGER R; PACINI G
      BETA-CELL ACTIVITY AND HEPATIC INSULIN EXTRACTION FOLLOWING DEXAMETHASONE ADMINISTRATION IN HEALTHY-SUBJECTS

      Metabolism, clinical and experimental
    28. KOTZMANN H; RIEDL M; CLODI M; BARNAS U; KAIDER A; HOCKER P; LUGER A
      THE INFLUENCE OF GROWTH-HORMONE SUBSTITUTION THERAPY ON ERYTHROID ANDMYELOID PROGENITOR CELLS AND ON PERIPHERAL-BLOOD CELLS IN ADULT PATIENTS WITH GROWTH-HORMONE DEFICIENCY

      European journal of clinical investigation
    29. LUDVIK B; NOLAN J; THOMASETH K; PACINI G; CLODI M; PRAGER R; OLEFSKY J
      DIRECT ASSESSMENT OF SECRETION, KINETICS AND CLEARANCE OF B-CELL PEPTIDES DURING HEPATIC VEIN CATHETERIZATION

      Diabetologia
    30. CLODI M; THOMASETH K; HERMANN K; PACINI G; KAUTZKYWILLER A; BORCHERT K; PRAGER R; LUDVIK B
      KINETICS AND DISTRIBUTION OF INTRAVENOUSLY ADMINISTERED IAPP IN HUMANS

      Diabetologia
    31. RIEDL M; KOTZMANN H; CLODI M; PACINI G; WAGNER O; RABENSTEINER D; PRAGER R; LUGER A
      EFFECT OF GROWTH-HORMONE REPLACEMENT THERAPY ON GLUCOSE-METABOLISM INGROWTH-HORMONE DEFICIENT ADULTS

      Diabetologia
    32. CLODI M; HERMANN K; PACINI G; THOMASETH K; KAUTZKYWILLER A; PRAGER R; LUDVIK D
      ISLET AMYLOID POLYPEPTIDE DISTRIBUTION AND KINETICS IN HUMANS AND ITSRELATIONSHIP TO KIDNEY-FUNCTION

      Diabetes
    33. LUDVIK B; NOLAN JJ; THOMASETH K; PACINI G; CLODI M; PRAGER R
      DIRECT ASSESSMENT OF SECRETION, KINETICS AND CLEARANCE OF BETA-CELL PEPTIDES DURING HEPATIC VEIN CATHETERIZATION

      Diabetes
    34. CLODI M; KLOTZMANN H; FISCHER G; RIEDL M; PRESSLICH O; SCHNEIDER C; DIAMANT K; LUGER A
      LIFE-THREATENING HEMOLYSIS IN A 27 YEAR-OLD DRUG-ADDICT

      European psychiatry
    35. KOTZMANN H; LINKESCH M; LUDVIK B; CLODI M; LUGER A; SCHERNTHANER G; PRAGER R; KLAUSER R
      EFFECT OF DANAZOL-INDUCED CHRONIC HYPERGLUCAGONEMIA ON GLUCOSE-TOLERANCE AND TURNOVER

      European journal of clinical investigation
    36. KAUTZKYWILLER A; PACINI G; THOMASETH K; RABENSTEINER D; CLODI M; LUDVIK B; WALDHAUSL W; PRAGER R
      IAPP AND INSULIN KINETICS AND INSULIN SENSITIVITY IN GESTATIONAL DIABETES-MELLITUS

      Diabetologia
    37. SVOBODA T; KOTZMANN H; CLODI M; BERNECKER P; GEYER G; LUGER A
      THE NON ERGOT D2-DOPAMINE AGONIST CV-205-502 DECREASES GROWTH-HORMONECONCENTRATIONS IN ACROMEGALIC PATIENTS

      Endocrine research
    38. LANGLE F; SOLIMAN T; NEUHOLD N; WIDHALM G; NIEDERLE B; ROKA S; KASERER K; BLAUENSTEINER W; DAM K; CLODI M; FLORES J; LOIDL A; SCHWARZLMULLER B; HUBER E; JAHL G; WAMPRECHTSHAMMER K; ROKA R
      CD15 (LEUM1) IMMUNOREACTIVITY - PROGNOSTIC FACTOR FOR SPORADIC AND HEREDITARY MEDULLARY-THYROID CANCER

      World journal of surgery
    39. PIRKER W; BRUCKE T; RIEDL M; CLODI M; LUGER A; ASENBAUM S; PODREKA I; DEECKE L
      IODINE-123-IBZM-SPECT - STUDIES IN 15 PATIENTS WITH PITUITARY-TUMORS

      Journal of neural transmission
    40. KOTZMANN H; SVOBODA T; BERNECKER P; CLODI M; WOLOSZCZUK W; NIEDERLE B; WALDHAUSL W; LUGER A
      DISODIUMPAMIDRONATE (APD) - AN EFFECTIVE DRUG IN THE TREATMENT OF HYPERACALCEMIA IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM

      Wiener Klinische Wochenschrift
    41. KOTZMANN H; KOLLER M; CZERNIN S; CLODI M; SVOBODA T; RIEDL M; BOLTZNITULESCU G; ZIELINSKI CC; LUGER A
      EFFECT OF ELEVATED GROWTH-HORMONE CONCENTRATIONS ON THE PHENOTYPE ANDFUNCTIONS OF HUMAN-LYMPHOCYTES AND NATURAL-KILLER-CELLS

      Neuroendocrinology
    42. LUDVIK B; CLODI M; KAUTZKYWILLER A; SCHULLER M; GRAF H; HARTTER E; PACINI G; PRAGER R
      INCREASED LEVELS OF CIRCULATING ISLET AMYLOID POLYPEPTIDE IN PATIENTSWITH CHRONIC-RENAL-FAILURE HAVE NO EFFECT ON INSULIN-SECRETION

      The Journal of clinical investigation
    43. KAUTZKYWILLER A; THOMASETH K; PACINI G; CLODI M; LUDVIK B; STRELI C; WALDHAUSL W; PRAGER R
      ROLE OF ISLET AMYLOID POLYPEPTIDE SECRETION IN INSULIN-RESISTANT HUMANS

      Diabetologia
    44. KAUTZKYWILLER A; TOMASETH K; CLODI M; LUDVIK B; WALDHAUSL W; PRAGER R; PACINI G
      DEXAMETHASONE ENHANCES BETA-CELL ACTIVITY IN HUMANS

      Diabetologia
    45. FURNSINN C; LEUVENINK H; RODEN M; NOWOTNY P; SCHNEIDER B; ROHAC M; PIEBER T; CLODI M; WALDHAUSL W
      ISLET AMYLOID POLYPEPTIDE INHIBITS INSULIN-SECRETION IN CONSCIOUS RATS

      The American journal of physiology
    46. GISSLINGER H; SVOBODA T; CLODI M; GILLY B; LUDWIG H; HAVELEC L; LUGER A
      INTERFERON-ALPHA STIMULATES THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS INVIVO AND INVITRO

      Neuroendocrinology
    47. PACINI G; THOMASETH K; KAUTZKYWILLER A; CLODI M; WALDHAUSL W; PRAGER R
      ISLET AMYLOID POLYPEPTIDE SECRETION AND KINETICS IN INSULIN-RESISTANTHYPERTENSIVE PATIENTS

      Diabetologia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/19 alle ore 05:17:32